|
US$359.00 ยท In stock
Delivery: <= 4 days. True-PDF full-copy in English will be manually translated and delivered via email.
GB/T 27533-2024: Diagnostic techniques for canine parvovirus disease
Status: Valid GB/T 27533: Evolution and historical versions
| Standard ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | Status | PDF |
| GB/T 27533-2024 | English | 359 |
Add to Cart
|
4 days [Need to translate]
|
Diagnostic techniques for canine parvovirus disease
| Valid |
GB/T 27533-2024
|
| GB/T 27533-2011 | English | 209 |
Add to Cart
|
3 days [Need to translate]
|
Diagnostic techniques for canine parvovirus disease
| Valid |
GB/T 27533-2011
|
PDF similar to GB/T 27533-2024
Basic data | Standard ID | GB/T 27533-2024 (GB/T27533-2024) | | Description (Translated English) | Diagnostic techniques for canine parvovirus disease | | Sector / Industry | National Standard (Recommended) | | Classification of Chinese Standard | B41 | | Classification of International Standard | 11.220 | | Word Count Estimation | 18,124 | | Date of Issue | 2024-12-31 | | Date of Implementation | 2025-07-01 | | Older Standard (superseded by this standard) | GB/T 27533-2011 | | Issuing agency(ies) | State Administration for Market Regulation, China National Standardization Administration | GB/T 27533-2024: Diagnostic techniques for canine parvovirus disease---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
ICS 11.220
CCSB41
National Standard of the People's Republic of China
Replaces GB/T 27533-2011
Diagnostic technology of canine parvovirus disease
Released on 2024-12-31
2025-07-01 Implementation
State Administration for Market Regulation
The National Standardization Administration issued
Table of Contents
Preface III
Introduction IV
1 Scope 1
2 Normative references 1
3 Terms and Definitions 1
4 Abbreviations 1
5 Biosafety measures 1
6 Clinical Diagnosis 2
7 Sample collection, processing and storage 3
8 Colloidal gold immunochromatography 4
9 Virus isolation and identification 4
10 Hemagglutination and hemagglutination inhibition test (HA/HI) 5
11 PCR 6
12 Fluorescence PCR 8
13 Comprehensive judgment 9
Appendix A (Normative) Preparation of Reagent Solutions 10
Appendix B (Informative) PCR, fluorescent PCR primers and probe sequences 11
Appendix C (Informative) Electrophoresis of Canine Parvovirus PCR Reaction Products 12
Appendix D (Informative) Canine Parvovirus Fluorescence PCR Amplification Curve Figure 13
Foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for standardization work Part 1.Structure and drafting rules for standardization documents"
Drafting.
This document replaces GB/T 27533-2011 "Diagnostic technology for canine parvovirus disease". Compared with GB/T 27533-2011, except for the structural adjustment,
In addition to the integration and editorial changes, the main technical changes are as follows.
--- Added abbreviations (see Chapter 4);
--- Added biosafety measures (see Chapter 5);
--- Added epidemiology (see 6.1);
--- Added routine blood test (see 6.3);
--- Added colloidal gold immunochromatography (see Chapter 8);
---Added fluorescence PCR (see Chapter 12);
--- Added comprehensive judgment (see Chapter 13).
Please note that some of the contents of this document may involve patents. The issuing organization of this document does not assume the responsibility for identifying patents.
This document was proposed by the Ministry of Agriculture and Rural Affairs of the People's Republic of China.
This document is under the jurisdiction of the National Technical Committee on Animal Health Standardization (SAC/TC181).
This document was drafted by. Qingdao Agricultural University, Fengshi (Qingdao) Marine Technology Co., Ltd., China Animal Health and Epidemiology Center,
Qingdao Haihua Biological Group Co., Ltd., Hebei North University, Shandong Academy of Agricultural Sciences, Qingdao Chengyang District Agricultural and Rural Service Center,
Changchun Sino Biotechnology Co., Ltd., Shandong Animal Disease Prevention and Control Center, Shanghai Customs Animal and Plant and Food Inspection and Quarantine Technology Center
Center, Qingdao Batfei Technology Development Co., Ltd., Chongqing Animal Disease Prevention and Control Center, and Zibo Zhangdian District Animal Husbandry and Fishery Service Center.
The main drafters of this document are. Zhang Hongliang, Shan Hu, Ma Qingxia, Su Hong, Li Yifei, Liu Gang, Zhang Ruihua, Xiao Ying, Zhu Weimin, Song Xiaoming,
Yang Ruimei, Sun Shengfu, Zhou Fang, Xia Zhenqiang, Xu Chao, Lin Jiaxu, Huang Bing, Yu Yongle, Huang Juan, Qin Zhihua, Luan Weili, Li Mingyi, Li Guimei,
Liu Lirong, Li Jian, Ma Fenglong, Zhang Chuanmei, Li Randong, Wen Jianxin, Qin Xiaobing, Ma Jing.
The previous versions of this document and the documents it replaces are as follows.
---First published in.2011 as GB/T 27533-2011;
---This is the first revision.
Introduction
An infectious disease of canines and mustelids. The main symptoms of the disease are severe vomiting, hemorrhagic enteritis, significant leukopenia, and myocarditis.
There are two types of symptoms, enteritis type and myocarditis type. More than 50% of clinical cases are mixed enteritis and myocarditis type.
Animal diseases.
Canine parvovirus belongs to the Parvoviridae family and the genus Parvovirus. It is a non-enveloped single-stranded DNA
Virus. The nucleotide homology of CPV with parvoviruses such as feline panleukopenia virus (FPLV) and mink enteritis virus (MEV) exceeds
98%. Gene sequence analysis of different isolates found that CPV is prone to produce new mutants through antigenic drift, and there are 4 subtypes.
CPV-2, CPV-2a, CPV-2b and CPV-2c. CPV can agglutinate the red blood cells of rhesus monkeys, hamsters, pigs, horses and cats, but cannot agglutinate the red blood cells of humans, cattle,
Sheep, rabbit, mouse and chicken red blood cells, so hemagglutination specificity is also one of the reference indicators for identifying the virus. The disease is easily confused with canine distemper and canine coronavirus.
It is difficult to confuse it with other diseases such as viral infection and requires a combination of clinical diagnosis and laboratory testing for confirmation.
Diagnostic technology of canine parvovirus disease
1 Scope
This document describes the clinical diagnosis of canine parvovirus disease, sample collection, processing and storage, colloidal gold immunochromatography, virus isolation
Identification, hemagglutination and hemagglutination inhibition test, PCR, fluorescence PCR and other methods.
This document applies to the diagnosis and surveillance of canine parvovirus disease.
2 Normative references
The contents of the following documents constitute the essential clauses of this document through normative references in this document.
For referenced documents without a date, only the version corresponding to that date applies to this document; for referenced documents without a date, the latest version (including all amendments) applies to
This document.
GB/T 6682 Specifications and test methods for water used in analytical laboratories
GB 19489 General requirements for laboratory biosafety
NY/T 541 Technical Specification for Collection, Storage and Transportation of Veterinary Diagnostic Samples
3 Terms and definitions
There are no terms or definitions that require definition in this document.
4 Abbreviations
The following abbreviations apply to this document.
BHQ. black hole quencher
CPE. cytopathic effect
Ct. cycle threshold
FAM.6-carboxyfluorescein
5 Biosafety measures
The sample collection, processing and storage operations shall be carried out in accordance with the provisions of NY/T 541.
Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of GB/T 27533-2024_English be delivered?Answer: Upon your order, we will start to translate GB/T 27533-2024_English as soon as possible, and keep you informed of the progress. The lead time is typically 2 ~ 4 working days. The lengthier the document the longer the lead time. Question 2: Can I share the purchased PDF of GB/T 27533-2024_English with my colleagues?Answer: Yes. The purchased PDF of GB/T 27533-2024_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet. Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay. Question 5: Should I purchase the latest version GB/T 27533-2024?Answer: Yes. Unless special scenarios such as technical constraints or academic study, you should always prioritize to purchase the latest version GB/T 27533-2024 even if the enforcement date is in future. Complying with the latest version means that, by default, it also complies with all the earlier versions, technically.
|